Sonia Dragulin-Otto MSc AstraZeneca

Sonia is a Senior Scientist in Biopharmaceutical Development at AstraZeneca working in the Formulation Sciences group. Having started her career in analytical sciences, she has been responsible for many aspects formulation development for monoclonal antibody, RNA and adenovirus-based combination products including regulatory filings, primary container characterization, compatibility and stability. During her time as formulation lead across multiple molecule teams, the characterization of deep-cold storage of drug substance and drug product, and the effects of freeze-thaw cycles have been specific areas of focus for Sonia. She is based in Maryland, US.